Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Alexander

Showing results (71-80 of 267) with videos related to

Pageof 27
Sort By:
Journal of Oncology Practice|November 19, 2016
Management of Malignant Peritoneal Mesothelioma Using Cytoreductive Surgery and Perioperative ChemotherapyPaul H Sugarbaker, Kiran K Turaga, H Richard Alexander, et al.
Annals of Surgical Oncology|January 28, 2017
Ushering in a New Era for Regional TherapiesKiran K Turaga, T Clark Gamblin, Robert Edwards, et al.
Gynecologic Oncology|March 30, 2004
Pseudo-Meigs' syndrome secondary to isolated colorectal metastasis to ovary: a case report and review of the literatureElizabeth D Feldman, Marybeth S Hughes, Pamela Stratton, et al.
Annals of Surgical Oncology|May 17, 2018
Together We Make a DifferenceKiran K Turaga, T Clark Gamblin, H Richard Alexander, et al.
The Knee|February 17, 2019
Why do patients not kneel after total knee replacement? Is neuropathic pain a contributing factor?James Richard Alexander Smith, John Abraham Mathews, Lindsay Osborne, et al.
Annals of Surgical Oncology|March 19, 2015
Moving fast and moving slowKiran K Turaga, T Clark Gamblin, H Richard Alexander, et al.
American Journal of Hematology|June 16, 2007
The impact of major surgery on blood coagulation factors and thrombin generationMcDonald K Horne, Paula K Merryman, Ann M Cullinane, et al.
Cytokine|June 7, 2005
Endothelial monocyte activating polypeptide-II induced gene expression changes in endothelial cellsAnita T Tandle, Chiara Mazzanti, H Richard Alexander, et al.
Annals of Surgical Oncology|January 7, 2016
Regional Therapies for Advanced Cancer: Update for 2016Kiran K Turaga, T Clark Gamblin, H Richard Alexander, et al.
BMJ Open|April 5, 2019
Changes in ocular signs and symptoms in patients switching from bimatoprost-timolol to tafluprost-timolol eye drops: an open-label phase IV studyRupert Richard Alexander Bourne, Kai Kaarniranta, Katrin Lorenz, et al.
Pageof 27

Showing results (71-80 of 267) with videos related to

Sort By:
Pageof 27
Journal of Oncology Practice|November 19, 2016
Management of Malignant Peritoneal Mesothelioma Using Cytoreductive Surgery and Perioperative ChemotherapyPaul H Sugarbaker, Kiran K Turaga, H Richard Alexander, et al.
Annals of Surgical Oncology|January 28, 2017
Ushering in a New Era for Regional TherapiesKiran K Turaga, T Clark Gamblin, Robert Edwards, et al.
Gynecologic Oncology|March 30, 2004
Pseudo-Meigs' syndrome secondary to isolated colorectal metastasis to ovary: a case report and review of the literatureElizabeth D Feldman, Marybeth S Hughes, Pamela Stratton, et al.
Annals of Surgical Oncology|May 17, 2018
Together We Make a DifferenceKiran K Turaga, T Clark Gamblin, H Richard Alexander, et al.
The Knee|February 17, 2019
Why do patients not kneel after total knee replacement? Is neuropathic pain a contributing factor?James Richard Alexander Smith, John Abraham Mathews, Lindsay Osborne, et al.
Annals of Surgical Oncology|March 19, 2015
Moving fast and moving slowKiran K Turaga, T Clark Gamblin, H Richard Alexander, et al.
American Journal of Hematology|June 16, 2007
The impact of major surgery on blood coagulation factors and thrombin generationMcDonald K Horne, Paula K Merryman, Ann M Cullinane, et al.
Cytokine|June 7, 2005
Endothelial monocyte activating polypeptide-II induced gene expression changes in endothelial cellsAnita T Tandle, Chiara Mazzanti, H Richard Alexander, et al.
Annals of Surgical Oncology|January 7, 2016
Regional Therapies for Advanced Cancer: Update for 2016Kiran K Turaga, T Clark Gamblin, H Richard Alexander, et al.
BMJ Open|April 5, 2019
Changes in ocular signs and symptoms in patients switching from bimatoprost-timolol to tafluprost-timolol eye drops: an open-label phase IV studyRupert Richard Alexander Bourne, Kai Kaarniranta, Katrin Lorenz, et al.
Pageof 27